Navigating the high costs of cancer care: opportunities for patient engagement

被引:8
作者
Gunn, Alexander H. [1 ,2 ]
Sorenson, Corinna [2 ,3 ,4 ]
Greenup, Rachel A. [5 ,6 ,7 ]
机构
[1] Duke Univ, Sch Med, Durham, NC 27710 USA
[2] Duke Univ, Duke Margolis Ctr Hlth Policy, Durham, NC 27710 USA
[3] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC 27708 USA
[4] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27710 USA
[5] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
[6] Yale Univ, Smilow Canc Hosp, New Haven, CT 06510 USA
[7] Yale Univ, Yale Canc Ctr, New Haven, CT 06510 USA
关键词
digital technology; financial navigation; financial toxicity; patient engagement; shared decision-making; value-based insurance design; SHARED DECISION-MAKING; CHOOSING WISELY RECOMMENDATIONS; HEALTH-CARE; PRICE TRANSPARENCY; CLINICAL ONCOLOGY; AMERICAN SOCIETY; FINANCIAL TOXICITY; OF-LIFE; BREAST; PREFERENCES;
D O I
10.2217/fon-2021-0341
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over the past decade, the financial burden of cancer care on patients and their families has garnered increased attention. Many of the potential solutions have focused on system-level interventions such as adopting value-based payment models and negotiating drug prices; less consideration has been given to actions at the patient level to address cancer care costs. We argue that it is imperative to develop and support patient-level strategies that engage patients and consider their preferences, values and individual circumstances. Opportunities to meet these aims and improve the economic experience of patients in oncology are discussed, including: shared decision-making and communication, financial navigation and treatment planning, digital technology and alternative care pathways, and value-based insurance design. Lay abstract The financial burden of cancer care on patients and their families is a growing problem and action is critically needed to alleviate the high costs of such care. So far, potential solutions have focused on system-level interventions, with less consideration given to solutions at the patient level. This review argues that it is imperative to develop and support patient-level strategies that engage patients. Next, the review presents evidence of the interplay between patient preferences and values and the costs of cancer care. Finally, opportunities to enhance engagement and improve the economic experience of patients in oncology are discussed, including: shared decision-making and communication, financial navigation and treatment planning, digital technology and alternative care pathways, and value-based insurance design.
引用
收藏
页码:3729 / 3742
页数:14
相关论文
共 110 条
  • [1] Advisory Board, 2017, CANC CAR TRANSF PLAY
  • [2] Value-Based Insurance Design Improves Medication Adherence Without An Increase In Total Health Care Spending
    Agarwal, Rajender
    Gupta, Ashutosh
    Fendrick, A. Mark
    [J]. HEALTH AFFAIRS, 2018, 37 (07) : 1057 - 1064
  • [3] Financial Hardships Experienced by Cancer Survivors: A Systematic Review
    Altice, Cheryl K.
    Banegas, Matthew P.
    Tucker-Seeley, Reginald D.
    Yabroff, K. Robin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02):
  • [4] [Anonymous], 2019, FIN TOX CANC TREATM
  • [5] [Anonymous], 2018, BLUE CROSS NC LAUNCH
  • [6] [Anonymous], 2019, Cancer Facts Figures for African Americans 2019-2021, P1
  • [7] Assessment of Financial Toxicity Among Older Adults With Advanced Cancer
    Arastu, Asad
    Patel, Arpan
    Mohile, Supriya Gupta
    Ciminelli, Joseph
    Kaushik, Ramya
    Wells, Megan
    Culakova, Eva
    Lei, Lianlian
    Xu, Huiwen
    Dougherty, David W.
    Mohamed, Mostafa R.
    Hill, Elaine
    Duberstein, Paul
    Flannery, Marie Anne
    Kamen, Charles Stewart
    Pandya, Chintan
    Berenberg, Jeffrey L.
    Aarne Grossman, Valerie G.
    Liu, Yang
    Loh, Kah Poh
    [J]. JAMA NETWORK OPEN, 2020, 3 (12) : E2025810
  • [8] Baltz A, 2020, J CLIN ONCOL, V38
  • [9] Interventions supporting cost conversations between patients and clinicians: A systematic review
    Barrera, Francisco J.
    Ponce, Oscar J.
    Espinoza, Nataly R.
    Alvarez-Villalobos, Neri A.
    Zuniga-Hernandez, Jorge A.
    Prokop, Larry J.
    Gionfriddo, Michael R.
    Rodriguez-Gutierrez, Rene
    Brito, Juan P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (05)
  • [10] Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.
    Basch, Ethan M.
    Deal, Allison Mary
    Dueck, Amylou C.
    Bennett, Antonia Vickery
    Atkinson, Thomas Michael
    Scher, Howard I.
    Kris, Mark G.
    Hudis, Clifford A.
    Sabbatini, Paul
    Dulko, Dorothy
    Rogak, Lauren J.
    Barz, Allison Emily
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18)